Differences in severe exacerbations rates and healthcare utilisation in COPD populations in the UK and France - Archive ouverte HAL Access content directly
Journal Articles BMJ open respiratory research Year : 2022

Differences in severe exacerbations rates and healthcare utilisation in COPD populations in the UK and France

(1) , (2, 3) , (3) , (3) , (3) , (4) , (5) , (6, 7) , (1) , (3)
1
2
3
4
5
6
7

Abstract

Introduction Chronic obstructive pulmonary disease (COPD) is a leading cause of mortality in Europe; however, it is important to understand how clinical practice patterns differ between countries and how this might relate to disease outcomes, to identify ways of improving local disease management. We aimed to describe and compare the management of patients with COPD in the UK and France between 2008 and 2017. Methods We used data from the Clinical Practice Research Datalink GOLD and Hospital Episode Statistics in the UK and the Echantillon Généraliste des Bénéficiaire in France to identify patients with COPD each year between 2008 and 2017. We compared patient characteristics, all-cause mortality and COPD exacerbations each year between 2008 and 2017 for patients in the UK and France separately. Health care utilisation and COPD exacerbations in 2017 were compared between France and the UK using t-tests and χ 2 tests. Results Patients with COPD were similar in gender and comorbidities in both countries. Incidence of COPD exacerbations remained stable in the UK and France between 2007 and 2017. In 2017, the proportion of all-cause and COPD-related hospitalisations was greater in the UK than in France (43.9% vs 32.8% and 8.3% vs 4.9%, respectively; p<0.001) as was the proportion of patients visiting accident and emergency (A&E) (39.8% vs 16.2%, respectively; p<0.001). In addition, the mean length of stay in hospital for COPD-related causes was shorter in the UK than in France (6.2 days (SD 8.4) vs 10.5 days (SD 9.1), respectively; p<0.001). Discussion Overall, UK patients were more likely to go to A&E, be hospitalised for COPD-related causes and stay in hospital for fewer days after being admitted for COPD-related reasons compared with patients in France, illustrating a difference in health-seeking behaviours and access to healthcare.

Keywords

Fichier principal
Vignette du fichier
HannahWhittaker_BMJOpenRespRes_2022.pdf (421.63 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive

Dates and versions

hal-03805057 , version 1 (07-10-2022)

Licence

Attribution - NonCommercial - CC BY 4.0

Identifiers

Cite

Hannah Whittaker, Eric van Ganse, Faustine Dalon, Maeva Nolin, Claire Marrant-Micallef, et al.. Differences in severe exacerbations rates and healthcare utilisation in COPD populations in the UK and France. BMJ open respiratory research, 2022, 9 (1), pp.e001150. ⟨10.1136/bmjresp-2021-001150⟩. ⟨hal-03805057⟩
20 View
2 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More